HomeCompareFBTTX vs JNJ

FBTTX vs JNJ: Dividend Comparison 2026

FBTTX yields 1.58% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FBTTX wins by $1.9K in total portfolio value
10 years
FBTTX
FBTTX
● Live price
1.58%
Share price
$33.01
Annual div
$0.52
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.0K
Annual income
$174.82
Full FBTTX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FBTTX vs JNJ

📍 FBTTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFBTTXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FBTTX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FBTTX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FBTTX
Annual income on $10K today (after 15% tax)
$134.16/yr
After 10yr DRIP, annual income (after tax)
$148.60/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $555.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FBTTX + JNJ for your $10,000?

FBTTX: 50%JNJ: 50%
100% JNJ50/50100% FBTTX
Portfolio after 10yr
$21.0K
Annual income
$501.30/yr
Blended yield
2.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FBTTX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FBTTX buys
0
JNJ buys
0
No recent congressional trades found for FBTTX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFBTTXJNJ
Forward yield1.58%3.36%
Annual dividend / share$0.52$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$22.0K$20.0K
Annual income after 10y$174.82$827.78
Total dividends collected$1.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FBTTX vs JNJ ($10,000, DRIP)

YearFBTTX PortfolioFBTTX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,858$157.83$10,676$355.77+$182.00FBTTX
2$11,778$160.16$11,407$389.39+$371.00FBTTX
3$12,765$162.37$12,198$426.53+$567.00FBTTX
4$13,823$164.46$13,056$467.62+$767.00FBTTX
5$14,957$166.44$13,987$513.12+$970.00FBTTX
6$16,172$168.31$14,998$563.56+$1.2KFBTTX
7$17,474$170.08$16,098$619.52+$1.4KFBTTX
8$18,869$171.75$17,295$681.69+$1.6KFBTTX
9$20,363$173.33$18,599$750.82+$1.8KFBTTX
10$21,964$174.82$20,022$827.78+$1.9KFBTTX

FBTTX vs JNJ: Complete Analysis 2026

FBTTXStock

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.

Full FBTTX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FBTTX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FBTTX vs SCHDFBTTX vs JEPIFBTTX vs OFBTTX vs KOFBTTX vs MAINFBTTX vs ABBVFBTTX vs MRKFBTTX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.